EWALD STEPHEN P 4

What Happened
Stephen P. Ewald, General Counsel and Corporate Secretary of Medpace Holdings, exercised stock options on February 17, 2026, acquiring 3,500 shares by paying $138.87 per share for a total cash outlay of $486,045. The same filing reports a simultaneous disposition/conversion of 3,500 derivative shares at $0.00. The primary action here was an option exercise (an acquisition); the zero-dollar disposition suggests part of the derivative interest was surrendered or converted as part of the transaction rather than sold for cash.

Key Details

• Transaction date: 2026-02-17. Exercise price for acquired shares: $138.87; total reported cash paid: $486,045.
• Reported derivative disposition: 3,500 shares at $0.00 (reported as a derivative disposition).
• Shares owned after the transaction: not disclosed in the filing.
• Footnote: The option vested in full on February 15, 2026. (F1)
• Filing timeliness: Reported on 2026-02-18 for a 2026-02-17 transaction — appears timely (no late filing indicated).

Context

• This was an option exercise (transaction code M). The filing does not report an open-market sale of the acquired shares for cash. The reported $0.00 derivative disposition commonly reflects shares/options surrendered or converted to satisfy exercise costs or withholding obligations rather than a public sale.
• As with all insider filings, this is factual reporting of the transaction and should not be interpreted as a definitive signal of future stock performance.